2-((1H-1,2,4-Triazol-1-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one

Catalog No. :
ACAXXY098
CAS No. :
95987-35-2
Molecular Formula :
C13H13N3O
Molecular Weight :
227.27

IUPAC Name:2-((1H-1,2,4-triazol-1-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one

2-((1H-1,2,4-Triazol-1-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$170.00Login to see priceInquiryInquiry
5g97%$508.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((1H-1,2,4-Triazol-1-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
IUPAC Name2-((1H-1,2,4-triazol-1-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
Molecular FormulaC13H13N3O
Molecular Weight227.27
SMILESO=C1C(CN2N=CN=C2)CCC3=C1C=CC=C3
InChI KeyAOWPSMZJLXJTAH-UHFFFAOYSA-N
Synonym2-(1,2,4-triazol-1-ylmethyl)-1-tetralinone;2-(1,2,4-triazol-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;2-(1,2,4-triazol-1-ylmethyl)tetralin-1-one;2-(1H-1,2,4-triazol-1-ylmethyl)-3,4-dihydronaphthalen-1(2H)-one;1(2H)-naphthalenone, 3,4-dihydro-2-(1H-1,2,4-triazol-1-ylmethyl)-;1(2H)-naphthalenone, 3,4-dihydro-2-(1H-1,2,4-triazol-1-ylm;2-(1H-(1,2,4)-triazol-1-yl)methyl-3,4-dihydro-2H-naphthalen-1-one
CAS No.95987-35-2

Synthetic Route by SureRoute

1. ACAXXY098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8 In Stock
  4. Then
  5. ACAXXY098 route product structure diagram
    ACAXXY09895987-35-2
Inquiry

2. ACAXXY098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8 In Stock
  4. Then
  5. ACAXXY098 route product structure diagram
    ACAXXY09895987-35-2
Inquiry

Comments (0)